HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David R Staskin Selected Research

trospium chloride (Ceris)

9/2011Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
2/2011Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
3/2010Extended-release trospium chloride improves quality of life in overactive bladder.
12/2009Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.
3/2008Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
11/2006Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
8/2005A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.
12/2004Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder.
12/2003Trospium chloride: a quaternary amine with unique pharmacologic properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David R Staskin Research Topics

Disease

27Overactive Urinary Bladder (Overactive Bladder)
01/2019 - 01/2003
6Urge Urinary Incontinence (Urge Incontinence)
02/2011 - 12/2003
5Constipation
04/2011 - 12/2003
4Urinary Incontinence
01/2019 - 06/2006
3Cognitive Dysfunction
10/2012 - 01/2005
2Lower Urinary Tract Symptoms
05/2010 - 07/2008
2Stress Urinary Incontinence
09/2006 - 08/2002
2Sleepiness
11/2005 - 12/2004
1Wounds and Injuries (Trauma)
01/2019
1Dizziness (Lightheadedness)
04/2011
1Nocturia
04/2011
1Chronic Disease (Chronic Diseases)
01/2010
1Inflammation (Inflammations)
07/2008
1Urinary Retention
07/2008
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
11/2006
1Confusion (Bewilderment)
11/2005
1Disorders of Excessive Somnolence (Hypersomnia)
12/2004
1Xerostomia
12/2002
1AIDS-Related Complex (ARC)
10/2002

Drug/Important Bio-Agent (IBA)

11Muscarinic AntagonistsIBA
10/2012 - 06/2005
9trospium chloride (Ceris)FDA LinkGeneric
09/2011 - 12/2003
8Cholinergic Antagonists (Anticholinergics)IBA
10/2012 - 12/2003
4oxybutynin (Tavor)FDA LinkGeneric
10/2012 - 04/2009
3Pharmaceutical PreparationsIBA
01/2010 - 12/2002
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2011 - 12/2009
2Cholinergic Agents (Cholinergics)IBA
12/2009 - 12/2003
2Solifenacin SuccinateFDA Link
06/2006 - 11/2005
1NickelIBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1salicylhydroxamic acid (SHAM)IBA
05/2012
1Dutasteride (Avodart)FDA Link
05/2010
1Tolterodine Tartrate (Detrol)FDA Link
05/2010
1fesoterodineFDA Link
01/2010
1Prostate-Specific Antigen (Semenogelase)IBA
07/2008
1darifenacinFDA Link
11/2005
1TabletsIBA
12/2004
1AminesIBA
12/2003
1Proteins (Proteins, Gene)FDA Link
12/2003
1Biological ProductsIBA
10/2002

Therapy/Procedure

6Therapeutics
10/2018 - 12/2003
3Bathroom Equipment
09/2011 - 08/2005
3Suburethral Slings (Tension-Free Vaginal Tape)
09/2006 - 08/2002
2Drug Therapy (Chemotherapy)
11/2005 - 01/2005